Valuation: ResMed, Inc.

Market Cap 27.68B 24.34B 22.61B 20.8B 39.01B 2,680B 39.7B 270B 105B 1,307B 104B 102B 4,536B P/E 2026 *
18.1x
P/E 2027 * 16.9x
Enterprise Value 26.85B 23.62B 21.94B 20.18B 37.84B 2,600B 38.52B 262B 102B 1,268B 101B 98.63B 4,400B EV / Sales 2026 *
4.75x
EV / Sales 2027 * 4.36x
Free-Float
75.61%
Yield 2026 *
1.27%
Yield 2027 * 1.37%
1 day+2.36%
1 week-1.96%
Current month+0.11%
1 month-0.72%
3 months-11.26%
6 months-23.64%
Current year-19.01%
1 week 190.21
Extreme 190.21
198.73
1 month 190.21
Extreme 190.21
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
8/6/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
1/6/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.32%-1.96%-28.67%-10.58% 27.68B
-2.10%+5.81%+18.61%-1.42% 213B
-0.26%-5.29%-4.81%-25.17% 135B
+2.10%-2.00%-30.72%+4.62% 117B
+1.94%+0.48%-58.35%-15.20% 64.78B
+3.54%+1.35%+14.63%-4.93% 48.26B
+2.64%-0.65%-27.16%-31.91% 43.08B
-0.83%+5.31%+15.03%+8.39% 39.47B
-1.87%+1.99%+26.09%+31.14% 37.55B
-2.00%+3.42%+79.34%+2.64% 29.78B
Average +0.55%-3.32%+0.40%-4.24% 75.59B
Weighted average by Cap. +0.07%-4.83%-1.85%-5.92%

Financials

2026 *2027 *
Net sales 5.65B 4.97B 4.62B 4.25B 7.96B 547B 8.11B 55.21B 21.53B 267B 21.21B 20.75B 926B 5.97B 5.25B 4.88B 4.48B 8.41B 578B 8.56B 58.31B 22.74B 282B 22.4B 21.92B 978B
Net income 1.55B 1.36B 1.26B 1.16B 2.18B 150B 2.22B 15.11B 5.89B 73.04B 5.81B 5.68B 253B 1.61B 1.42B 1.32B 1.21B 2.27B 156B 2.31B 15.74B 6.14B 76.12B 6.05B 5.92B 264B
Net Debt -827M -727M -675M -621M -1.16B -80.05B -1.19B -8.08B -3.15B -39.05B -3.1B -3.04B -135B -1.65B -1.45B -1.35B -1.24B -2.32B -159B -2.36B -16.09B -6.27B -77.77B -6.18B -6.05B -270B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
25/07/26 USD 195.14 +1.69% 87,890
23/07/26 USD 191.89 -0.53% 1,012,467
22/07/26 USD 192.91 -1.48% 971,174
21/07/26 USD 195.80 -1.41% 1,112,740
20/07/26 USD 198.61 -0.19% 1,037,424
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
191.89USD
Average target price
248.60USD
Spread / Average Target
+29.55%

Quarterly revenue - Rate of surprise